VSL#3 for ulcerative colitis: Growing evidence?

Gastroenterology

Volumn 140, Issue 5, 2011, Pages 1685-1686

  Scott, Frank I ^a   Aberra, Faten ^a  

^a HOSPITAL OF THE UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOMODULATING AGENT; MESALAZINE; PLACEBO; VSL3;

DRUG SAFETY; ENDOSCOPY; HUMAN; NOTE; PRIORITY JOURNAL; RECTUM HEMORRHAGE; REMISSION; SCORING SYSTEM; SUPPLEMENTATION; TREATMENT OUTCOME; ULCERATIVE COLITIS;

EID: 79955395988     PISSN: 00165085     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.gastro.2011.03.032     Document Type: Note

References (0)